Hypoxia-inducible Factors, Stem Cells, and Cancer

Overview

Journal Cell

Publisher Cell Press

Specialty Cell Biology

Date 2007 May 8

PMID 17482542

Citations 595

Authors

Brian Keith

M Celeste Simon

Affiliations

Soon will be listed here.

Abstract

Regions of severe oxygen deprivation (hypoxia) arise in tumors due to rapid cell division and aberrant blood vessel formation. The hypoxia-inducible factors (HIFs) mediate transcriptional responses to localized hypoxia in normal tissues and in cancers and can promote tumor progression by altering cellular metabolism and stimulating angiogenesis. Recently, HIFs have been shown to activate specific signaling pathways such as Notch and the expression of transcription factors such as Oct4 that control stem cell self renewal and multipotency. As many cancers are thought to develop from a small number of transformed, self-renewing, and multipotent "cancer stem cells," these results suggest new roles for HIFs in tumor progression.

Citing Articles

Effect of FLT3 ligand on the gene expression of TIM-3, HIF1-α, and TNF-α in an acute myeloid leukemia cell line.

Heidari F, Kazemi-Sefat N, Feizollahi P, Gerdabi S, Pourfathollah A, Ebtekar M Mol Biol Rep. 2025; 52(1):313.

PMID: 40085277 DOI: 10.1007/s11033-025-10396-4.

The Role of RAC2 and PTTG1 in Cancer Biology.

Rakoczy K, Szymanska N, Stecko J, Kisiel M, Sleziak J, Gajewska-Naryniecka A Cells. 2025; 14(5).

PMID: 40072059 PMC: 11899714. DOI: 10.3390/cells14050330.

Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy.

Shao X, Zhao X, Wang B, Fan J, Wang J, An H Theranostics. 2025; 15(5):1689-1714.

PMID: 39897552 PMC: 11780529. DOI: 10.7150/thno.103636.

Development of an AI model for predicting hypoxia status and prognosis in non-small cell lung cancer using multi-modal data.

Zhou L, Mao C, Fu T, Ding X, Bertolaccini L, Liu A Transl Lung Cancer Res. 2025; 13(12):3642-3656.

PMID: 39830777 PMC: 11736583. DOI: 10.21037/tlcr-24-982.

Exploring the Metabolic Impact of FLASH Radiotherapy.

Geirnaert F, Kerkhove L, Montay-Gruel P, Gevaert T, Dufait I, De Ridder M Cancers (Basel). 2025; 17(1.

PMID: 39796760 PMC: 11720285. DOI: 10.3390/cancers17010133.

References

Ohlstein B, Kai T, Decotto E, Spradling A . The stem cell niche: theme and variations. Curr Opin Cell Biol. 2004; 16(6):693-9. DOI: 10.1016/j.ceb.2004.09.003. View

Kehler J, Tolkunova E, Koschorz B, Pesce M, Gentile L, Boiani M . Oct4 is required for primordial germ cell survival. EMBO Rep. 2004; 5(11):1078-83. PMC: 1299174. DOI: 10.1038/sj.embor.7400279. View

Tai M, Chang C, Kiupel M, Webster J, Olson L, Trosko J . Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2004; 26(2):495-502. DOI: 10.1093/carcin/bgh321. View

Mancini S, Mantei N, Dumortier A, Suter U, MacDonald H, Radtke F . Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. Blood. 2004; 105(6):2340-2. DOI: 10.1182/blood-2004-08-3207. View

Huntly B, Gilliland D . Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer. 2005; 5(4):311-21. DOI: 10.1038/nrc1592. View

Hochedlinger K, Yamada Y, Beard C, Jaenisch R . Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell. 2005; 121(3):465-77. DOI: 10.1016/j.cell.2005.02.018. View

Raval R, Lau K, Tran M, Sowter H, Mandriota S, Li J . Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol. 2005; 25(13):5675-86. PMC: 1157001. DOI: 10.1128/MCB.25.13.5675-5686.2005. View

Michor F, Hughes T, Iwasa Y, Branford S, Shah N, Sawyers C . Dynamics of chronic myeloid leukaemia. Nature. 2005; 435(7046):1267-70. DOI: 10.1038/nature03669. View

Kiel M, Yilmaz O, Iwashita T, Yilmaz O, Terhorst C, Morrison S . SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005; 121(7):1109-21. DOI: 10.1016/j.cell.2005.05.026. View

10.

Joseph N, Morrison S . Toward an understanding of the physiological function of Mammalian stem cells. Dev Cell. 2005; 9(2):173-83. DOI: 10.1016/j.devcel.2005.07.001. View

11.

Axelson H, Fredlund E, Ovenberger M, Landberg G, Pahlman S . Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol. 2005; 16(4-5):554-63. DOI: 10.1016/j.semcdb.2005.03.007. View

12.

Gustafsson M, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J . Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell. 2005; 9(5):617-28. DOI: 10.1016/j.devcel.2005.09.010. View

13.

Cowden Dahl K, Fryer B, Mack F, Compernolle V, Maltepe E, Adelman D . Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation. Mol Cell Biol. 2005; 25(23):10479-91. PMC: 1291235. DOI: 10.1128/MCB.25.23.10479-10491.2005. View

14.

Ohlstein B, Spradling A . The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature. 2005; 439(7075):470-4. DOI: 10.1038/nature04333. View

15.

Covello K, Kehler J, Yu H, Gordan J, Arsham A, Hu C . HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 2006; 20(5):557-70. PMC: 1410808. DOI: 10.1101/gad.1399906. View

16.

Loh Y, Wu Q, Chew J, Vega V, Zhang W, Chen X . The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006; 38(4):431-40. DOI: 10.1038/ng1760. View

17.

Lee T, Jenner R, Boyer L, Guenther M, Levine S, Kumar R . Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006; 125(2):301-13. PMC: 3773330. DOI: 10.1016/j.cell.2006.02.043. View

18.

Wilson A, Radtke F . Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett. 2006; 580(12):2860-8. DOI: 10.1016/j.febslet.2006.03.024. View

19.

Vescovi A, Galli R, Reynolds B . Brain tumour stem cells. Nat Rev Cancer. 2006; 6(6):425-36. DOI: 10.1038/nrc1889. View

20.

Morrison S, Kimble J . Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 2006; 441(7097):1068-74. DOI: 10.1038/nature04956. View